Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

novartis_window

Novartis’ Xolair shows strong retreatment efficacy at Phase 3 in chronic spontaneous urticaria

September 18, 2017
Research and Development, Sales and Marketing Novartis, Xolair, chronic spontaneous urticarial, pharma, pharmaceutical

Novartis has released new data demonstrating the efficacy of Xolair (omalizumab) in the treatment of chronic spontaneous urticaria (CSU), a …

News
sandoz

Sandoz psoriasis biosimilar tops reference product Humira in latest Phase 3 data

September 15, 2017
Medical Communications, Research and Development AbbVie, Humira, Novartis, Sandoz, adalimumab, biosimilar, biosimilars, pharma, pharmaceutical

Sandoz, the biologics and generics division of Novartis, has unveiled new Phase 3 data confirming the efficacy and safety profile …

News

Novartis’ Cosentyx proves long-term efficacy in psoriasis skin clearance

September 13, 2017
Research and Development Cosentyx, Novartis, pharma, pharmaceutical, psoriasis

At the European Academy of Dermatology and Venereology Congress in Geneva, Switzerland, Novartis unveiled new Phase 3 data for Cosentyx …

News

FDA accepts license application for Novartis’ rituximab biosimilar

September 12, 2017
Manufacturing and Production, Sales and Marketing Novartis, Rituxan, Sandoz, biosimilar, rituximab

Sandoz, Novartis’ generics and biosimilars division, has revealed that the FDA has accepted its Biologics License Application (BLA) for a …

News
novartis_window

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017
Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

News
narasimhan_2

Novartis exec designated as new CEO after Jimenez announces retirement

September 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …

Appointment
novartis_side_building

Novartis celebrates success of Gilenya in paediatric multiple sclerosis

September 5, 2017
Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals

Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …

News
joseph_jimenez

Novartis CEO Jimenez announces retirement in 2018

September 4, 2017
Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …

News
novartis_hq_day

CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017
Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …

News

Novartis names new Chief Digital Officer

August 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

Appointment

Novartis’ drug prevents heart attacks and cancer but faces major challenges

August 29, 2017
Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical

It would be expected that when a company releases data to show that its drug, previously only used in a …

News

Novartis names new Chief Digital Officer

August 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment, digital pharma, life sciences, pharma, pharmaceuticals

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

News

Novartis gets EU nod for potential blockbuster breast cancer drug

August 24, 2017
Sales and Marketing CDK4/6, Novartis, biotech, breast cancer, drugs, pharma, pharmaceutical

Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …

News
shutterstock_236161768

Novartis launches first large-scale smartphone-based study in multiple sclerosis

August 23, 2017
Research and Development MS, Novartis, life sciences, multiple sclerosis, pharma, pharmaceuticals

Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …

News
aedes_aegypti_mosquito

Novartis begins ‘next-generation’ malaria treatment trial

August 21, 2017
Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical

Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025